As the number of patients with dry AMD continues to rise, this session explores whether photobiomodulation should form part of the advice optometrists provide to their patients.

Watch this session to get insights into the evidence-based research and the documentation supporting different available technologies. Through selected patient cases, it addresses who may benefit, where the limitations lie, and the ethical considerations: is it more unethical to treat, or not to inform patients and offer treatment options?

This session took place at Clinical Conference in Norway on 22 September 2026.